LIMN – liminatus pharma, inc. - class a (US:NASDAQ)
Stock Stats
News
Liminatus Pharma, Inc. Announces Pricing of $4.0 Million Public Offering [Yahoo! Finance]
Liminatus Pharma, Inc. Announces Pricing of $4.0 Million Public Offering
Liminatus Pharma (NASDAQ:LIMN) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
Form 8-K Liminatus Pharma, Inc. For: Feb 27
Form SCHEDULE 13G Liminatus Pharma, Inc. Filed by: INTRACOASTAL CAPITAL, LLC
Form 8-K Liminatus Pharma, Inc. For: Feb 17
Form 424B4 Liminatus Pharma, Inc.
Form EFFECT Liminatus Pharma, Inc.
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.